Lactams
Medchemexpress LLC Laurocapram | 59227-89-3 | 99.4% | 281.48 | 5 G
Laurocapram is a chemical penetration enhancer that increases the permeability of compounds through the skin and mucous membranes, improving their local or systemic efficacy. It enhances the skin permeability of various hydrophilic and lipophilic compounds.
- Synergizes with β-lactam antibiotics like Cefixime, Penicillin G, and Polymyxin E to improve antibacterial activity against S. aureus, especially MRSA strains.
- Exhibits anti-infectious activity in MRSA-induced mouse pneumonia models.
- Ameliorates infection wounds in MRSA-administered mouse skin infection models.
- Alleviates pathological changes of lung tissue.
- Reduces pulmonary edema and bacterial load.
- Reduces skin infection wound area.
- Decreases levels of FN-γ, IL-6, and TNF-α.
eMolecules 50607-30-2 | 2,4-Piperidinedione | Combi-Blocks | MFCD08704814 | 113.116 | C5H7NO2 | 98.000 | O=C1CCNC(=O)C1 | 25g | 205391986
2,4-Piperidinedione | Combi-Blocks | 50607-30-2 | MFCD08704814 | 113.116 | C5H7NO2 | 98.000 | O=C1CCNC(=O)C1 | 25g | 205391986
Medchemexpress LLC Thalidomide-CH2NH2 (hydrochloride) | 444287-40-5 | 98.1% | 323.73 | 5 MG
Thalidomide-CH2NH2 hydrochloride is an analogue of Thalidomide that includes a primary amine, a versatile functional group capable of participating in various reactions. This product is intended for research use only and is not sold to patients.
- Analogue
- Features a primary amine, allowing for versatile reactions
Sigma Aldrich Fine Chemicals Biosciences Cefadroxil Related Compound B United States Pharmacopeia (USP) Reference Standard | 22252-43-3 | MFCD09750368 | 25MG
Cefadroxil Related Compound B United States Pharmacopeia (USP) Reference Standard | Mol Wt: 214.24 | 22252-43-3 | MFCD09750368 | 25MG
Cayman Chemical -ThalIdomIde 100mg
An immunomodulatory compound with diverse biological activities; prevents PMN chemotaxis at 1, 10, and 100 UG/ml; increases IL-2-induced proliferation and IFN-γ production in primary human T cells in vitro; enhances NK cell-mediated cytotoxicity in MM.1S multiple myeloma cells; reduces lung IL-6, TGF-β, VEGF, angiopoietin-1, angiopoietin-2, and collagen type Iα1 expression, inhibits pulmonary angiogenesis, and attenuates fibrosis in a mouse model of bleomycin-induced pulmonary fibrosis at 4 mg/animal; induces apoptosis in primary human embryonic fibroblasts (EC50 = 8.9 µM) and induces limb and eye defects in chicken embryos (EC50 = 50 UG/kg egg weight)